Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The American Journal of Gastroenterology
|
May 22, 2023
IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience
Anusha Shirwaikar Thomas, Seung Eun Lee, Malek Shatila, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events
Jia Luo, Jason A Beattie, Paige Fuentes, et al.
Inflammatory Bowel Diseases
|
January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Matthew C Choy, Dean Seah, David M Faleck, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 20, 2024
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry
Steven H Itzkowitz, Yue Jiang, Cristina Villagra, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
Yousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
The Journal of Experimental Medicine
|
December 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
Joan Shang, Diane Marie Del Valle, Graham J Britton, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Pooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Nature Communications
|
March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Pooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Nature Communications
|
January 7, 2023
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
Walid K Chatila, Henry Walch, Jaclyn F Hechtman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The American Journal of Gastroenterology
|
May 22, 2023
IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience
Anusha Shirwaikar Thomas, Seung Eun Lee, Malek Shatila, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events
Jia Luo, Jason A Beattie, Paige Fuentes, et al.
Inflammatory Bowel Diseases
|
January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Matthew C Choy, Dean Seah, David M Faleck, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 20, 2024
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry
Steven H Itzkowitz, Yue Jiang, Cristina Villagra, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
Yousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
The Journal of Experimental Medicine
|
December 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
Joan Shang, Diane Marie Del Valle, Graham J Britton, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Pooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Nature Communications
|
March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Pooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Nature Communications
|
January 7, 2023
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
Walid K Chatila, Henry Walch, Jaclyn F Hechtman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Page
of 4